Careers Media center Contacts

Arterium presents motion sickness medication

Arterium presents motion sickness medication

31 January 2020 | News

Arterium Corporation has presented a new product in Uzbekistan—Dramina motion sickness pills. The medicinal product's active ingredient is dimenhydrinate. Its purpose is to relieve motion sickness symptoms like dizziness, nausea, and vomiting in children and adults. Dramina quickly relieves symptoms of motion sickness, from which statistically every 6th adult and every 4th child suffers. Inducing histamine receptor blockade, the product exhibits anti-nauseant, anti-emetic, sedative, and anti-allergic action, as well as mitigates dizziness. Arterium Corporation exclusively markets Dramina in the Uzbek market as part of its partnership with Croatia's JDL.

Media gallery

Here you can find general information about the company intended for journalists and other stakeholders


For all media-related enquiries,
please contact us
mob.: +38050 446 71 20, +38095 278 92 80